Beijing GoBroad Hospital is a research-driven institution dedicated to the diagnosis and treatment of complex diseases, clinical research, and the industrial translation of biopharmaceuticals and medical devices. As a key public service platform for clinical research in Beijing, the hospital brings together China’s leading clinical research experts and a comprehensive support team. By leveraging its strong clinical research capabilities, Beijing GoBroad integrates the city’s extensive resources in basic research, startup enterprises, and scientific institutions to build a high-level ecosystem for medical innovation.

Located in the Changping Life Science Park in Beijing, the hospital spans approximately 100,000 square meters and houses 500 planned beds, including 100 designated for early-phase research. With specialized focuses on solid tumors, hematologic malignancies, and neuroscience, Beijing GoBroad Hospital was officially inaugurated in July 2023.

As a pioneer in the research-oriented hospital model, Beijing GoBroad Hospital is also a flagship institution of GoBroad Healthcare Group. Founded in 2017, GoBroad Healthcare Group operates four core divisions: the Center for Complex Diseases, the Clinical Research Center, the Precision Diagnostics Center, and the Data Intelligence Center. Driven by a mission to advance medical innovation, the group has assembled top-tier clinical experts and built an integrated platform bridging industry and clinical practice.

More than half of GoBroad’s team specializes in clinical innovation and translational medicine, supported by dedicated units such as the Early-Phase Clinical Research Center, Central Laboratory, Imaging Core, Pathology Core, Cardiac Safety Assessment Center, Clinical Pharmacology, Medical Affairs, and Biostatistics. Since its establishment, GoBroad Healthcare Group has experienced rapid growth, providing professional services for hundreds of innovative drug companies and supporting numerous clinical trials. Most importantly, its work has brought new hope to thousands of patients battling complex and life-threatening diseases.